Article Details

Chinese biopharma Taibang raises $300m, stirs relisting murmurs - Nikkei Asia

Retrieved on: 2022-08-02 14:39:06

Tags for this article:

Click the tags to see associated articles and topics

Chinese biopharma Taibang raises $300m, stirs relisting murmurs - Nikkei Asia. View article details on hiswai:

Excerpt

The biopharmaceutical company, formerly known as China Biologic Products, was previously listed on Nasdaq. It was taken private in April 2021 by a ...

Article found on: asia.nikkei.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up